TECNIS Synergy™ IOL in Modern Practice
Sponsored by Johnson & Johnson Medical Affairs
Genetic Testing Informs Risk for Keratoconus & Confirms Dystrophies
Sponsored by Avellino
KOL Knockout™ Cataract Edition: Heavy Hitters Discuss Using Next-Generation Technologies to Maximize Outcomes in Complex Cases
This activity is supported by an unrestricted educational grant from Alcon.
FDA-Approved Corneal Cross-Linking: The What and The Why
Editorially independent content supported by Glaukos
The Modern State of
Dry Eye: Part 2
Patient Selection, Innovative Approaches to Therapy, and the Latest Data
Sponsored by Oyster Point Pharma
Global Ophthalmology and Access to Eye Care
Editorially independent content supported by Alcon, Allergan, Dompé, Johnson & Johnson Vision, and Zeiss
An Inside Look at Innovations in Ophthalmology
Editorially independent content, supported with advertising from: Avellino, Johnson & Johnson Vision, New World Medical, Nova Eye Medical, Sight Sciences, and Zeiss
Is Presbyopia Finally Taking Center Stage?
Editorially independent content supported by AbbVie/Allergan and Johnson & Johnson Vision.
Vivity® and PanOptix® Expand Patients’ Visual Possibilities – Dr. Morgan Micheletti, MD
Thinking Differently In Glaucoma
Editorially independent content supported by SightSciences
Best Practices on Referring Patients With Symptomatic Vitreous Opacities
Editorially Independent Content, Supported with Advertising from Alcon Surgical and LumiThera